Literature DB >> 1526661

Respiratory burst capacity of activated macrophages is resistant to depression by erythrocyte phagocytosis.

M G Schwacha1, D J Loegering.   

Abstract

The present study evaluated whether macrophage activation would reduce the depression in the capacity of macrophages to produce H2O2 following EIgG phagocytosis. Macrophage activation was accomplished by exposing inflammatory rat peritoneal macrophages to 10 units of IFN gamma for 72 h. IFN gamma treatment caused a four to fivefold increase in phorbol myristate acetate (PMA)-triggered H2O2 production, but Fc receptor phagocytic function was unaltered. IFN gamma-activated macrophages were able to phagocytize a greater number of EIgG before a decrease in PMA-triggered H2O2 production was observed and the level of H2O2 production did not fall below that of untreated-inflammatory macrophages that had not received an EIgG phagocytic challenge. The depression in Fc receptor phagocytic function was unaltered with macrophage activation. These results indicate that activated macrophages are resistant to the depression of respiratory burst capacity caused by erythrocyte phagocytosis and suggests that IFN gamma treatment may be effective in preventing the impairment of host defense against bacterial infection that is associated with erythrocyte phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1526661     DOI: 10.1007/bf00917621

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  27 in total

Review 1.  Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effects on the oxidase.

Authors:  C F Nathan; S Tsunawaki
Journal:  Ciba Found Symp       Date:  1986

2.  Characterization of murine macrophage Fc receptor-dependent phagocytosis and antibody-dependent cellular cytotoxicity during in vitro culture with interferons-gamma, alpha/beta and/or fetal bovine serum.

Authors:  R W Leu; J A Rummage; M J Horn
Journal:  Immunobiology       Date:  1989-02       Impact factor: 3.144

Review 3.  Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity.

Authors:  R D Schreiber
Journal:  Contemp Top Immunobiol       Date:  1984

4.  Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.

Authors:  K W Talmadge; H Gallati; F Sinigaglia; A Walz; G Garotta
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

5.  Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice.

Authors:  G Bukholm; B P Berdal; C Haug; M Degré
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

6.  Modulation of infection by gamma interferon treatment following trauma.

Authors:  M J Hershman; H C Polk; J D Pietsch; R E Shields; S R Wellhausen; G Sonnenfeld
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  Scavengers of reactive oxygen intermediates do not mediate the depression of macrophage hydrogen peroxide production caused by erythrocyte phagocytosis.

Authors:  M G Schwacha; D J Loegering; L M Commins; P W Gudewicz
Journal:  Inflammation       Date:  1991-12       Impact factor: 4.092

8.  Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon.

Authors:  K Watanabe; K Kagaya; T Yamada; Y Fukazawa
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Incorporation of recombinant gamma interferon into liposomes enhances its ability to induce peritoneal macrophage antitoxoplasma activity.

Authors:  J W Mellors; R J Debs; J L Ryan
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.